Results

Total Results: 1,187 records

Showing results for "weeks".

401. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure_research-protocol.pdf
     April 11, 2011 -  Duration of followup: ≥8 weeks.  No minimum sample size. … Prospective longitudinal study  N ≥ 100 for adults; N ≥ 10 for children  Duration of followup: ≥8 weeks

402. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-screening_research-protocol.pdf
     November 16, 2010 - If no response is received within 6 weeks, we will assess the study based upon the available data provided … case of failure to communicate with the primary investigators, or if there is no response within 6 weeks

403. Glaucoma-Treatment Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-treatment_research-protocol.pdf
     November 16, 2010 - If no response is received within 6 weeks, we will assess the study based upon the available data provided … case of failure to communicate with the primary investigators, or if there is no response within 6 weeks

404. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
     May 24, 2010 - a recent study isolated C. difficile spores from air samples in a United Kingdom hospital, 4 to 7 weeks … Online: May 24, 2010 Antibiotic and non-standard treatments: variable, generally ranging from 4 weeks

405. Alcohol-Misuse Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse_research-protocol.pdf
     April 28, 2010 - updated after draft report goes out for peer review Length of followup At least 6 months (24 weeks

406. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0094_04-09-2009.pdf
     January 01, 2009 - Effective Health Care Topic Number(s): 0051 Document Completion Date: 6-12-09 1 Results of Topic Selection Process & Next Steps  Therapies for autism spectrum disorders will go forward for refinement as a comparative effectiveness or effectiveness review. The scope of this topic, including pop…

407. Alcohol-Misuse-Drug-Therapy Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
     January 27, 2012 - Studies were required to treat patients with a medication for a minimum of 12 weeks in an outpatient … month had greater improvement on the mental health summary score than those receiving placebo at 24 weeks … Another trial (included in KQ 1 but not in KQ 4), which compared naltrexone with placebo for 12 weeks … We required that trials have at least 12 weeks of followup from the time of medication initiation,

408. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - and Human Development (NICHD), about half of stillbirths (i.e., miscarriages that occur after 20 weeks

409. Cancer-Anemia-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
     April 01, 2013 - erythropoietic-stimulating agents (ESAs) increase the number of red blood cells within about 2 to 3 weeks

410. AHRQ Slide Template-Widescreen
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-child-adolesc-mental-health-grand-rounds.pptx
     May 22, 2025 - Reporting on clinical ADHD Diagnosis Treatment Monitoring Any diagnostic tool Any treatment study of >4 weeks … These treatments are generally conducted over multiple sessions over the course of several weeks or months

411. Management of Insomnia Disorder in Adults: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
     August 01, 2017 - . �� Studies of pharmacological interventions rarely lasted more than 6 weeks.

412. Disposition of Comments: CER 227 Noninvasive Nonpharmacological Treatment for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-227-noninvasive-nonpharm-chronic-pain-comments.pdf
     April 16, 2020 - For example, if a study intervention lasted 8 weeks and measurements were taken at 8 and 16 weeks. … intervention and was not included in the analysis andthe 16 week measurements were we classified as 8 weeks

413. Diagnosis of Celiac Disease: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/celiac-disease_clinician.pdf
     July 01, 2016 - defined as failure to spontaneously eliminate the capsule from the gastrointestinal (GI) tract within 2 weeks

414. Prostate-Cancer-Therapies-Update Consumer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_consumer.pdf
     January 01, 2016 - Radiation treatment is given a few minutes a day, 5 days a week, for 8 to 9 weeks.

415. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
     October 01, 2014 - indicated it has produced a rapid (within 2 hours) and relatively sustained (approximately 1 to 2 weeks … manufacturers may target different areas of the brain with their respective DBS devices. 1 About 2 to 4 weeks … for 40 minutes) produced a rapid (within 2 hours) and relatively sustained (approximately 1 to 2 weeks

416. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - however, the remainder (64% [692 of 1,074]) of initial responders had relapsed disease at up to 18 weeks … During the first 4 weeks after treatment, 40.8% of the rifaximin group and 31.2% of the placebo group

417. Depression-Treatment-Ssri Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_executive.pdf
     April 01, 2012 - The interventions were a minimum of 4 weeks duration and three of the studies involved dose escalation … are associated with greater likelihood of a positive treatment response to combined therapy at 12 weeks … If a patient does not respond to a full dose of fluvoxamine for at least 12 weeks, what alternatives

418. Disposition of Comments: CER 230 Therapies for Clinically Localized Prostate Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-230-prostate-cancer-comments.pdf
     September 17, 2020 - Disposition of Comments: CER 230 Therapies for Clinically Localized Prostate Cancer Comparative Effectiveness Review Disposition of Comments Report Title: Therapies for Clinically Localized Prostate Cancer Draft report available for public comment from June 01, 2020 to June 29, 2020. Citation: D…

419. Disposition of Comments: Comparative Effectiveness Review No. 238 Cervical Ripening in the Outpatient Setting (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-outpatient-setting-comments.pdf
     March 22, 2021 - There is strong pressure by some to electively induce all women at 39 weeks and this report will be

420. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - ultrasound guidance. 24-27 Typically, multiple injections are given over the course of several weeks … severity at baseline was 8.2 (range 7–10); it was 3.2 (range 1–4) and 2.9 (range 0–4) at 12 and 24 weeks … range 32–77) at baseline; it was 77.3 points (range 60–95) and 88.9 points (range 69–98) at 12 and 24 weeks … than 3 months duration; n=261) who were treated with three intra-articular PRP injections every 2 weeks